The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer’s disease families
Open accessAbstract
Pathogenic mutations in APP, PSEN1, PSEN2, MAPT and GRN have previously been linked to familial early onset forms of dementia. Mutation screening in these genes has been performed in either very small series or in single families with late onset AD (LOAD). Similarly, studies in single families have reported mutations in MAPT and GRN associated with clinical AD but no systematic screen of a large dataset has been performed to determine how frequently this occurs. We report sequence data for 439 probands from late-onset AD families with a history of four or more affected individuals. Sixty sequenced individuals (13.7%) carried a novel or pathogenic mutation. Eight pathogenic variants, (one each in APP and MAPT, two in PSEN1 and four in GRN) three of which are novel, were found in 14 samples. Thirteen additional variants, present in 23 families, did not segregate with disease, but the frequency of these variants is higher in AD cases than controls, indicating that these variants may also modify risk for disease. The frequency of rare variants in these genes in this series is significantly higher than in the 1,000 genome project (p = 5.09 × 10⁻⁵; OR = 2.21; 95%CI = 1.49-3.28) or an unselected population of 12,481 samples (p = 6.82 × 10⁻⁵; OR = 2.19; 95%CI = 1.347-3.26). Rare coding variants in APP, PSEN1 and PSEN2, increase risk for or cause late onset AD. The presence of variants in these genes in LOAD and early-onset AD demonstrates that factors other than the mutation can impact the age at onset and penetrance of at least some variants associated with AD. MAPT and GRN mutations can be found in clinical series of AD most likely due to misdiagnosis. This study clearly demonstrates that rare variants in these genes could explain an important proportion of genetic heritability of AD, which is not detected by GWAS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“suggesting that rare variants in genes associated with AD pathogenesis could explain a significant proportion of genetic heritability of AD, which is not detected by genomewide association studies (53)”
From Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4 (2014) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“A characteristic example involves a mutation screening study that showed that rare variants in amyloid  precursor protein, presenilin 1, and presenilin 2 increased the risk for AD in LOAD families, suggesting that rare variants in genes associated with AD pathogenesis could explain a significant proportion of genetic heritability of AD, which is not detected by genomewide association studies (53)”
From Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4 (2014) · cites this paper as [53]
In the citing paper
“In support, sequencing studies have identified rare variants in APP, PSEN1, and PSEN2 that increase risk for LOAD [157].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citationHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Self-citationGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Self-citationNaj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901
Self-citationRole of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798
The Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C. S., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,416
Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219
Cited by
Sorted by citations
Items 201–300 of 320
The Dangers of Direct-to-Consumer Genetic Testing for Alzheimer’s Disease
Lacaze, P. A., Tiller, J. M., & Ryan, J. L. (2017) · Journal of Bioethical Inquiry · doi:10.1007/s11673-017-9817-6 · Cited by 9
Scelsi, M. A., Napolioni, V., Greicius, M. D., Altmann, A., Initiative, A. D. N., & the Alzheimer’s Disease Sequencing Project (ADSP) (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008517 · Cited by 11
Бочарова, А. В., Вагайцева, К. В., Marusin, A. V., Zhukova, N., Zhukova, I. A., Minaycheva, L. I., Makeeva, O. A., & Степанов, В. А. (2021) · Genes · doi:10.3390/genes12101647 · Cited by 9
Xiong, W., Cai, J., Li, R., Wen, C., Tan, H., & Database, O. B. O. T. A. D. N. I. (. (2022) · Genes · doi:10.3390/genes13050838 · Cited by 8
Lessons from genetic studies in Alzheimer disease
Nicolas, G. (2024) · Revue Neurologique · doi:10.1016/j.neurol.2023.12.006 · Cited by 9
Large‐scale sequencing studies expand the known genetic architecture of Alzheimer's disease
Xue, D., Bush, W. S., Renton, A. E., Marcora, E. M., Bis, J. C., Kunkle, B. W., The Alzheimer's Disease Sequencing Project, Boerwinkle, E., DeStefano, A. L., Farrer, L. A., et al. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12255 · Cited by 8
Self-citationDong, L., Li, J., Liu, C., Mao, C., Wang, J., Lei, D., Huang, X., Chu, S., Hou, B., Feng, F., et al. (2021) · Brain and Behavior · doi:10.1002/brb3.2373 · Cited by 7
Novel Susceptibility Loci for Alzheimer's DXSisease
Reitz, C. (2015) · Future Neurology · doi:10.2217/fnl.15.42 · Cited by 10
Cruchaga, C., & Goate, A. (2015) · Nature · doi:10.1038/nature14037 · Cited by 8
Self-citationCell-type-resolved genetic variation shapes inflammatory bowel disease risk
Alegbe, T., Harris, B. T., Fachal, L., Ramirez-Navarro, L., Tutert, M., Krzak, M., Ghouraba, M., Strickland, M., Ozols, M., Cohen, C. E., et al. (2026) · Nature · doi:10.1038/s41586-026-10627-z · Cited by 10
Distribution of Big Tau Isoforms in the Human Central and Peripheral Nervous System
Koppisetti, R. K., Barthélemy, N. R., Horie, K., Ly, C. V., Roberts, K. F., Koutarapu, S., Perrin, R. J., Franklin, E. E., Pedicone, C., Orrick, J., et al. (2026) · Annals of Neurology · doi:10.1002/ana.78300 · Cited by 7
Self-citationBradley, J. L., Pottier, C. P., da Fonseca, E. L., Kurup, J. T., Western, D., Wang, C., Neupane, A., Ray, N. R., Jean‐Francois, M. N., Ali, M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70377 · Cited by 9
Self-citationNovel progranulin variants do not disrupt progranulin secretion and cleavage
Karch, C. M. M., Jeng, A. T., Skorupa, T., Cruchaga, C., & Goate, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.004 · Cited by 7
Self-citationXiang, J., Wang, X., Gao, Y., Li, T., Cao, R., Yan, T., Ma, Y., Niu, Y., Xue, J., & Wang, B. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00890 · Cited by 7
Τhe Greek Variant in APP Gene: The Phenotypic Spectrum of APP Mutations
Kalampokini, S., Georgouli, D., Patrikiou, E., Provatas, A., Valotassiou, V. J., Georgoulias, P., Spanaki, C., Hadjigeorgiou, G. M., & Xiromerisiou, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212355 · Cited by 7
Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer disease
Buckles, V., Xiong, C., Bateman, R. J., Hassenstab, J. J., Allegri, R., Berman, S., Chhatwal, J. P., Danek, A., Fagan, A. M., Ghetti, B. F., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12505 · Cited by 7
Self-citationMathioudakis, L., Dimovasili, C., Bourbouli, M., Latsoudis, H., Kokosali, E., Gouna, G., Vogiatzi, E., Basta, M., Kapetanaki, S., Panagiotakis, S., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.07.002 · Cited by 7
Wang, D., Scalici, A., Wang, Y., Lin, H., Pitsillides, A., Heard‐Costa, N. L., Cruchaga, C., Ziegemeier, E., Bis, J. C., Fornage, M., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251320375 · Cited by 8
Self-citationPrevention of Alzheimer’s Disease: Intervention Studies
Mangialasche, F., Xu, W., & Kivipelto, M. (2013) · InTech eBooks · doi:10.5772/55034 · Cited by 7
Beaton, D., ADNI, Saporta, G., & Abdi, H. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/598888 · Cited by 7
Patwekar, M., Patwekar, F., Khan, S. M., Sharma, R., & Kumar, D. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266295495240415114919 · Cited by 8
Stanciu, G. D., Ababei, D. C., Rusu, R.-N., Bild, V., & Tamba, B.-I. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061270 · Cited by 6
Evolution of Alzheimer’s disease pathogenesis conception
Stefanova, N. A., & Kolosova, N. G. (2016) · Moscow University Biological Sciences Bulletin · doi:10.3103/s0096392516010119 · Cited by 6
N’Songo, A., Carrasquillo, M. M., Wang, X., Nguyen, T., Asmann, Y. W., Younkin, S. G., Allen, M., Duara, R., Custo, M. T. G., Graff‐Radford, N. R., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161185 · Cited by 6
Self-citationThe Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
EPR-Proton Qubits’ Role in Evolution and Age-Related Disease
Grant Cooper, W. (2017) · Physical Science & Biophysics Journal · doi:10.23880/psbj-16000104 · Cited by 5
A variant in GRN of Spanish origin presenting with heterogeneous phenotypes
Menéndez‐González, M., García-Martínez, A., Fernández‐Vega, I., Pitiot, A., & Álvarez, V. (2022) · Neurología (English Edition) · doi:10.1016/j.nrleng.2022.10.001 · Cited by 5
Genetic Variants and Related Biomarkers in Sporadic Alzheimer’s Disease
Guerreiro, R. J., Brás, J., Toombs, J., Heslegrave, A., Hardy, J., & Zetterberg, H. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0062-6 · Cited by 6
Study of Alzheimer family case reveals hemochromotosis-associated HFE mutation
Artemov, A. V., Boulygina, E., Tsygankova, S., Nedoluzhko, A., Chekanov, N., Gruzdeva, N. M., Селезнева, Н. Д., Рощина, И. Ф., Si, G., Velichkovsky, B. B., et al. (2014) · Human Genome Variation · doi:10.1038/hgv.2014.4 · Cited by 5
Missense and loss‐of‐function variants at GWAS loci in familial Alzheimer's disease
Gunasekaran, T. I., Reyes‐Dumeyer, D., Faber, K. M., Goate, A., Boeve, B. F., Cruchaga, C., Pericak‐Vance, M. A., Haines, J. L., Rosenberg, R. N., Tsuang, D. W., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14221 · Cited by 4
Self-citationEpidemiology and Clinical Diagnosis
Cohen, R. M. (2013) · PET Clinics · doi:10.1016/j.cpet.2013.08.001 · Cited by 5
FTLD-MAPT mutations and short 5′UTR Tau mRNAs increase Tau translation
da Costa, P. J., Perret, A., Buée, L., Hamdane, M., & Martin, F. (2024) · NAR Molecular Medicine · doi:10.1093/narmme/ugae023 · Cited by 4
MAPT mutations in amyotrophic lateral sclerosis: clinical, neuropathological and functional insights
Bertier, S. D., Lautrette, G., Amador, M. D. M., Miki, T., Boillée, S., Lobsiger, C. S., Bohl, D., Darios, F. D., Machat, S., Duchesne, M., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13007-1 · Cited by 4
Jin, S. C., Benítez, B. A., Deming, Y. K., & Cruchaga, C. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_18 · Cited by 4
Self-citationHorn, J. V. V., Irimia, A., Torgerson, C., Bhattrai, A., Jacokes, Z., & Vespa, P. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24084 · Cited by 4
Pathogenesis of Alzheimer’s Disease
Castellani, R. J., Plascencia‐Villa, G., & Perry, G. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_162-1 · Cited by 4
The role of oxidative stress in the development of Alzheimer's disease
Nikolenko, V. N., Rizaeva, N. A., Bulygin, K. V., Anokhina, V. M., & Bolotskaya, A. A. (2022) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2022-4-68-74 · Cited by 6
In silico modeling of pathogenic or possibly pathogenic point mutations in PSEN2
Cai, Y., Bagyinszky, E., An, S. S. A., & Kim, S. (2016) · Molecular & Cellular Toxicology · doi:10.1007/s13273-016-0050-x · Cited by 4
Contributions of rare and common variation to early-onset and atypical dementia riskPreprint
Wright, C., Taylor, J. W., Cochran, J. N., Lawlor, J. M. J., Moyers, B. A., Amaral, M. D., Bonnstetter, Z. T., Carter, P., Solomon, V., Myers, R., et al. (2023) · Molecular Case Studies · doi:10.1101/mcs.a006271 · Cited by 4
Dissecting Cellular Heterogeneity: Single-Cell Metabolomics for Unmasking Hidden Variations
Abdi, G., Jain, M., Bhardwaj, R., Thakkar, K., Dewangan, I., Dhariwal, R., & Tarighat, M. A. (2024) · Springer eBooks · doi:10.1007/978-981-97-7459-3_4 · Cited by 3
Identification of two pathogenic mutations in SORL1 in early-onset Alzheimer’s disease
Qiu, G., Zhu, F., & Xu, C. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.05.020 · Cited by 3
Wang, M., Sun, L., Xu, X., Dai, R., Tan, Q., Zhu, Y., Xu, A., Zheng, W., Tu, Y., Zhou, D., et al. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf063 · Cited by 3
The Epidemiology and Prevention of Alzheimer’s Disease and Projected Burden of Disease
Ngandu, T., Mangialasche, F., & Kivipelto, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-411464-7.00001-8 · Cited by 3
Singular cases of Alzheimer’s disease disclose new and old genetic “acquaintances”
Coppola, C., Saracino, D., Oliva, M., Cipriano, L., Puoti, G., Pappatà, S., Fede, G. D., Catania, M., Ricci, M., Cimini, S., et al. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04774-y · Cited by 3
Park, K. W., An, S. S. A., Bagyinszky, E., & Kim, S. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s128884 · Cited by 3
Cruchaga, C., & Goate, A. (2015) · Nature · doi:10.1038/nature14041 · Cited by 3
Self-citationLong term rescue of Alzheimer’s deficits in vivo by one-time gene-editing of App C-terminusPreprint
Aulston, B. D., Gimse, K., Bazick, H., Kramár, E. A., Pizzo, D. P., Shavarebi, F., Rust, T., Rosa, S. G., Parra‐Rivas, L. A., Sun, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.08.598099 · Cited by 4
Devadoss, D., Akkaoui, J., Nair, M., & Lakshmana, M. K. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1365752 · Cited by 3
Molecular Targets of Alzheimer’s Disease Treatment
Bharathi, K., Souza, F. J. D., Chandana, C., & Vishwanath, B. A. (2025) · Research Journal of Pharmacology and Pharmacodynamics · doi:10.52711/2321-5836.2025.00020 · Cited by 2
Romero‐Molina, C., Neuner, S. M., Ryszawiec, M., Pébay, A., Dominantly Inherited Alzheimer Network, Marcora, E. M., & Goate, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052565 · Cited by 3
Self-citationGenomic insights into the etiology of Alzheimer's disease: a review
Reitz (2014) · Advances in Genomics and Genetics · doi:10.2147/agg.s51293 · Cited by 2
Evolution Via Epr-Entanglement Algorithm
Cooper, W. G. (2017) · Journal of Biomedical Engineering and Medical Imaging · doi:10.14738/jbemi.42.2795 · Cited by 1
Consequences of EPR–Proton Qubits Populating DNA
Cooper, W. G. (2018) · Advances in quantum chemistry · doi:10.1016/bs.aiq.2017.12.001 · Cited by 2
Karaduman, T. (2020) · Türk doğa ve fen dergisi :/Türk doğa ve fen dergisi · doi:10.46810/tdfd.713624 · Cited by 2
A comprehensive analysis of copy number variation in a Turkish dementia cohort
Dehghani, N., Güven, G., Kun‐Rodrigues, C., Gouveia, C., Foster, K., Hanağası, H. A., Lohmann, E., Samancı, B., Gurvit, H. I., Bılgıç, B., et al. (2021) · Human Genomics · doi:10.1186/s40246-021-00346-z · Cited by 1
Cruchaga, C., Bradley, J. L., Western, D., Wang, C., da Fonseca, E. L., Neupane, A., Kurup, J. T., Ray, N. R., Jean‐Francois, M. N., Gorijala, P., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4480585/v1 · Cited by 2
Self-citationXia, Y., Liu, X., Cui, W., Zhi, Q., & Sun, Y. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00787-x · Cited by 1
Small noncoding RNAs: Pioneering a new therapeutic era in Alzheimer’s disease
Sahoo, S., Pattanaik, S., Kar, D. M., Prusty, S. K., & Sahu, P. K. (2025) · Gene · doi:10.1016/j.gene.2025.149827 · Cited by 1
Chande, K., Nirmal, R., Varpe, N., Doke, R. R., Vinchurkar, K., & Singh, S. K. (2025) · 3 Biotech · doi:10.1007/s13205-025-04527-8 · Cited by 1
Identification of CTHRC1 as a novel candidate for neurodevelopmental disorders
Xu, J., He, Y., Li, Z., Zhou, W.-X., Huang, C., Lu, L., Bajpai, A. K., & Li, M. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1737003 · Cited by 1
APP E590D mutation increases generation of Aβ and Aη peptides and exacerbates tauopathy
Liu, T., Wetzel, L., Roy, D., Zhang, K., Zhu, Z., Kumaraguru, P., Gorthi, V., Jeon, H., Woo, J. A., & Kang, D. E. (2026) · npj Dementia · doi:10.1038/s44400-026-00069-9 · Cited by 1
Phenotypic diversity of frontotemporal lobar degeneration in two novel GRN variants from Colombia
Barbosa-Carvajal, J. P., García‐García, M., Navarro, L. F. G., Zubiri, V., Gelvez, N. Y., López, G., Reyes, P., Garcia-Cifuentes, E. R., Aguillón, D., Acosta‐Uribe, J., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71475 · Cited by 1
Next-generation sequencing for complex disorders
Casals, F., & Bosch, E. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781107337459.018 · Cited by 1
PET in Neurological and Psychiatric Disorders: Technologic Advances and Clinical Applications
Matusch, A., & Kroll, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-40070-9_20 · Cited by 1
Genetics of Alzheimer's Disease: An Update
Tang, M., & Reitz, C. (2017) · Future Neurology · doi:10.2217/fnl-2017-0003 · Cited by 1
Chen, M., Kretzschmar, D., Verdile, G., & Lardelli, M. T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00025-7 · Cited by 2
A variant in GRN of Spanish origin presenting with heterogeneous phenotypes
Menéndez‐González, M., García-Martínez, A., Fernández‐Vega, I., Pitiot, A., & Álvarez, V. (2025) · Neurología · doi:10.1016/j.nrl.2022.09.004 · Cited by 1
Advances in Therapies and Scope for Personalized Medicine in Alzheimer’s Disease
Ravishankar, H. N., Dutta, A. K., Lewis, A. G., & Mohan, A. (2016) · Personalized Medicine · doi:10.2217/pme.15.49 · Cited by 1
Patel, S., Park, M. T. M., Chakravarty, M. M., & Knight, J. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/015065 · Cited by 1
Beaton, D., Rieck, J. R., Alhazmi, F. H., ADNI, & Abdi, H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/235945 · Cited by 1
Therapeutic approaches and development of genomic diagnostic tools for Usher syndrome
García, C. F. (2020) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/137034 · Cited by 1
Barthelson, K., Newman, M., & Lardelli, M. T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.16.431539 · Cited by 1
Cell-type-resolved genetic regulatory variation shapes inflammatory bowel disease riskPreprint
Alegbe, T., Harris, B., Fachal, L., Ramirez-Navarro, L., Tutert, M., Krzak, M., Ghouraba, M., Strickland, M., Ozols, M., Cohen, C. E., et al. (2025) · medRxiv · doi:10.1101/2025.06.24.25330216 · Cited by 3
Genetics of Obstructive Sleep Apnea
Helgadottir, H. T. (2013)
Chen, R., Hu, B.-Q., Zhang, D.-X., Zhang, Q., & Pang, C.-Y. (2012) · IEEE International Conference on Granular Computing (GrC) · doi:10.1109/grc.2012.6468605
The Genetics of Alzheimer’s Disease: Introduction and Perspective for the Future
Morgan, K., & Carrasquillo, M. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7309-1_1
DiGSNP: a web tool for Disease-Gene-SNP hierarchical prioritization
Navarro, C., Cano, C., Blanco, A. J., & García-Alcalde, F. (2012) · EMBnet journal · doi:10.14806/ej.18.b.556
Mutation schützt vor Alzheimer-Demenz
Endres, K. (2012) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-012-0464-5
Studies on caspase signaling in microglia
Rodhe, J. (2016) · Figshare
Genetic approaches to neurodegenerative disease
Takada, L. T. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.006
Cardiovascular and Retinal Vascular Changes in Preclinical Alzheimer's Disease
Santos, C. (2018) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-santos-claudia-2018
Zeng, L., Yang, C., Yang, M., Luo, S., & Chen, L. (2018) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2018.2475
The R278I Mutation of PSEN1 in the Familial Alzheimer Disease
Kim, J. H., Choi, S. H., & Lee, J. H. (2020) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2020.19.1.33
Du, Y. T. (2017) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
DPP6 gene in European American Alzheimer’s DiseasePreprint
Kirola, L., Budde, J., Wang, F., Norton, J. B., Morris, J. C., NIA-LOAD family study group, N., Cruchaga, C., & Fernández, M. V. (2020) · medRxiv · doi:10.1101/2020.10.23.20216408
Self-citationEntanglement-Enabled Information Processing Implies Human Consciousness Mechanism
Grant Cooper, W. (2018) · Physical Science & Biophysics Journal · doi:10.23880/psbj-16000106
Exercise-Mediated Autophagy and Alzheimer’s Disease
Kou, X., Zhang, M., Zhang, H., Kirberger, M., & Chen, N. (2021) · Springer eBooks · doi:10.1007/978-981-16-4525-9_7
Ma, M., Yu, Q., Delafield, D. G., Cui, Y., Li, Z., Wu, W., Shi, X., Gutierrez, A., Westmark, P. R., Xu, M. J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.09.467989
Beal, M. F. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717948965.793454071
Diagnosing Alzheimer’s Disease
Burke, A. D., Hall, G. R., Yaari, R., Fleisher, A., Dougherty, J., Young, J., Brand, H., & Tariot, P. N. (2015) · doi:10.1007/978-1-910315-22-4_2
journal, E. (2012) · EMBnet journal · doi:10.14806/ej.18.b.592
Comparative Modelling and Prediction of Mutant Structures in TREM2 Protein using Computational Tools
Mounika, K., & Anbarasu, K. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s04.174
Chujan, S., Cholpraipimolrat, W., & Satayavivad, J. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10549-9
Azmi, N. H. M., Suppiah, S., Ibrahim, N., Ibrahim, B., Seriramulu, V., Mohamad, M., Thilakavathy, K., Omar, N., Ibrahim, N., Razali, R., et al. (2024) · medRxiv · doi:10.1101/2024.01.04.24300735
Episodic Memory Loss: When Alzheimer’s Disease Is Not the Answer
García‐Roldán, E., Tsai, R. M., Berger, A. C., & Macías, E. F. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-240014
Systematic Review and Phenome‐Wide Scans of Genetic Associations with Vascular Cognitive Impairment
Diany, R., & Taliun, S. A. G. (2024) · Advanced Biology · doi:10.1002/adbi.202300692
Yang, Y., Bagyinszky, E., & An, S. S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179678
Genetic Research in Alzheimer’s Disease
Tepgeç, F., & Uyguner, Z. O. (2024) · doi:10.69860/nobel.9786053359166.8
Metadata
- Authors
- Cruchaga, C., Chakraverty, S., Mayo, K., Vallania, F. L. M., Mitra, R. D., Faber, K., Williamson, J., Bird, T., Diaz-Arrastia, R., Foroud, T. M., Boeve, B. F., Graff-Radford, N. R., St. Jean, P., Lawson, M., Ehm, M. G., Mayeux, R., Goate, A. M., & for the NIA-LOAD/NCRAD Family Study Consortium
- Affiliations
- Washington University in St. Louis (US)
- Indiana University Indianapolis (US)
- Columbia University (US)
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Mayo Clinic (US)
- GlaxoSmithKline (United States) (US)
- Corresponding author
- Cruchaga, Carlos
- Goate, Alison M.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-02-01
- Volume
- 7
- Issue
- 2
- Pages
- e31039
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3270040
- OpenAlex
- W2023381648
- Cited by
- 320
- References
- 66
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 23 · 2023: 12 · 2022: 20 · 2021: 25 · 2020: 25 · 2019: 10 · 2018: 22 · 2017: 28 · 2016: 26 · 2015: 22 · 2014: 29 · 2013: 32 · 2012: 17
- FWCI
- 21.43
- Type
- journal article
- Language
- en
- Update notices
- correction (2012-05-10)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Veterans Affairs
- Massachusetts General Hospital
- University of Southern California
- University of Pennsylvania (U24 AG026395)
- Northwestern University
- Foundation for Barnes-Jewish Hospital
- University of Washington
- University of Pittsburgh
- Rush University
- National Institutes of Health (5p30ns069329-02, 5r37ag015473-15)
- University of California, Los Angeles
- National Institute on Aging (AG 16208, R37AG15473, R37-AG015473, AG21886, R01AG035083, U24 AG21886, P 50 AG05681, R01AG041797, P50AG008702, P50AG005681, P01 AG0 3991, P01AG003991, AG035083, U24AG026395, P30AG013846, R01AG016208, AG026395, U24AG056270, P01AG026276, U24AG021886)
- National Institute of Mental Health (R01MH060009)
- National Institute of Neurological Disorders and Stroke (P30-NS069329, 1P30NS069329-01)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- late-onset Alzheimer's disease, familial Alzheimer's disease, rare variants, APP, presenilin 1, presenilin 2, MAPT, gene regulatory networks, pathogenic variants, genetic risk, heritability, novel variants, age of onset, penetrance, misdiagnosis, mutation detection
- MeSH terms
- Progranulins, Adult, Aged, Aged, 80 and over, Alzheimer Disease, Female, Humans, Male, Middle Aged, Mutation, Pedigree, Amyloid beta-Protein Precursor, tau Proteins, Genetic Predisposition to Disease, Intercellular Signaling Peptides and Proteins, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
